IPA to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference Dec 4, 2024 08:00AM
IPA Announces Closing of $1.265 Million Public Offering of Common Shares Dec 8, 2023 05:00PM
IPA Announces Pricing of $1.1 Million Public Offering of Common Shares Dec 6, 2023 07:00AM
ImmunoPrecise Antibodies (IPA) Announces Proposed Public Offering of Common Shares Dec 5, 2023 04:35PM
IPA Announces Proposed Public Offering of Common Shares Dec 5, 2023 04:35PM


Nov 24, 2021 08:02AM ImmunoPrecise to Present at the Benchmark Company’s Discovery One-on-One Virtual Video Investor Conference on Thursday December 2, 2021